Skin Prick Testing Guidelines for IgE-Mediated Allergies
Skin prick testing is the first-line diagnostic procedure for suspected IgE-mediated allergies, with intradermal testing reserved for cases where prick tests are negative but clinical suspicion remains high 1, 2.
Indications
Perform skin testing when:
- History suggests IgE-mediated immediate-type allergic disease (allergic rhinitis, asthma, anaphylaxis to aeroallergens, foods, venoms, or drugs) 2, 3
- For penicillin allergy specifically: only test patients with anaphylaxis history or recent suspected IgE-mediated reactions 1
- Do NOT test patients with histories inconsistent with allergy (headache, family history alone, isolated GI symptoms) 1
Contraindications
Absolute Contraindications
Relative Contraindications (Higher Risk Procedures)
Medication Discontinuation
Critical timing for medication withdrawal 4:
Must Discontinue
- H1-antihistamines (second-generation): 3 days minimum (all patients stopping ≥3 days had positive histamine controls) 4
- Tricyclic antidepressants (TCAs): discontinue if clinically able (odds ratio 6.33 for false-negative) 4
- Benzodiazepines: discontinue if clinically able (odds ratio 5.01 for false-negative) 4
- Quetiapine and mirtazapine: discontinue if clinically able 4
Minimal/No Interference (Can Continue)
- SSRIs (97% positive histamine controls) 4
- SNRIs (100% positive histamine controls) 4
- Proton pump inhibitors (97% positive histamine controls) 4
- Bupropion, eszopiclone, trazodone, zolpidem 4
Timing Considerations
- For drug allergy testing: optimal window is 4-6 weeks post-reaction 5
- Beyond 6 months, false-negative rates increase 5
- Chemotherapy reactions require earlier testing (within 2 weeks) due to treatment urgency 5
Procedural Steps
Test Location
- Volar (flexor) aspect of forearm (preferred—allows patient to witness reaction) 2, 3
- Upper back (alternative, less sensitive site) 2
Technique
Prick/Puncture Testing (First-Line) 1, 3:
- Place drop of allergen extract on skin
- Introduce needle through drop into upper epidermis
- Gently lift epidermis up
- Apply appropriate positive (histamine) and negative (saline) controls 1
Intradermal Testing (If Prick Negative) 1, 2:
- Draw up 0.05-0.07 mL in syringe
- Expel excess to obtain exactly 0.02 mL 1
- Inject to produce baseline 3-5 mm bleb 1
- More sensitive but less specific than prick testing 3
Use Standardized Extracts
- Standardized test extracts are recommended 2
- If non-standardized substances used and positive, perform control tests in healthy subjects to exclude non-specific reactions 2
Interpretation Criteria
Reading Time
- Read at 15-20 minutes 2
Positive Test Definition
The workgroup recommends defining positive tests by wheal size ≥3 mm greater than negative control (for both prick and intradermal), accompanied by flare ≥5 mm 1.
Alternative criteria from other sources:
- Prick test: mean wheal diameter ≥3 mm 2
- Intradermal test: mean wheal diameter ≥5 mm 2
- For drug allergy intradermal: wheal at 20 minutes measuring ≥initial wheal +3 mm 5
Validity Requirements
- Positive control (histamine) must be positive 1
- Negative control (saline) must be negative 1
- Results invalid if controls don't respond appropriately 1
Emergency Precautions
Systemic anaphylactic reactions are very rare but must be anticipated 2:
- Testing must be performed only by personnel trained and skilled in application and interpretation 1
- Preparedness to treat anaphylaxis is mandatory 1, 2
- Emergency treatment must be immediately available 2
Critical Pitfalls
Distinguishing Sensitization from Clinical Allergy
- More patients are sensitized (positive skin tests) than have corresponding symptoms 3
- Positive test alone does NOT equal clinical allergy 2
- Diagnosis requires correlation of positive skin test with clinical symptoms 3
- Clinically irrelevant sensitization should not lead to practical consequences 2